These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prostaglandin E2 inhibits the release of tumor necrosis factor-alpha, rather than interleukin 1 beta, from human macrophages. Fieren MW; van den Bemd GJ; Ben-Efraim S; Bonta IL Immunol Lett; 1992 Jan; 31(1):85-90. PubMed ID: 1548034 [TBL] [Abstract][Full Text] [Related]
3. Inflammatory fluids regulate TNF-alpha, but not IL-1 beta, production by human peritoneal macrophages. A study of patients on continuous ambulatory peritoneal dialysis with peritonitis. Hart PH; Jones CA; Finlay-Jones JJ J Leukoc Biol; 1993 Mar; 53(3):309-19. PubMed ID: 7681094 [TBL] [Abstract][Full Text] [Related]
4. Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis show a differential secretion of prostanoids and interleukin-1 beta. Fieren MW; van den Bemd GJ; Bonta IL Prostaglandins Leukot Essent Fatty Acids; 1992 Sep; 47(1):23-8. PubMed ID: 1438464 [TBL] [Abstract][Full Text] [Related]
5. Advanced glycation end products stimulate tumor necrosis factor-alpha and interleukin-1 beta secretion by peritoneal macrophages in patients on continuous ambulatory peritoneal dialysis. Rashid G; Korzets Z; Bernheim J Isr Med Assoc J; 2006 Jan; 8(1):36-9. PubMed ID: 16450750 [TBL] [Abstract][Full Text] [Related]
6. Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis have an increased capability to release tumour necrosis factor during peritonitis. Fieren MW; van den Bemd GJ; Bonta IL; Ben-Efraim S J Clin Lab Immunol; 1991 Jan; 34(1):1-9. PubMed ID: 1667936 [TBL] [Abstract][Full Text] [Related]
7. Cytokine patterns in the effluent of continuous ambulatory peritoneal dialysis: relationship to peritoneal permeability. Zemel D; Krediet RT Blood Purif; 1996; 14(2):198-216. PubMed ID: 8785036 [TBL] [Abstract][Full Text] [Related]
8. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. Zemel D; Koomen GC; Hart AA; ten Berge IJ; Struijk DG; Krediet RT J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688 [TBL] [Abstract][Full Text] [Related]
9. Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis. Zemel D; Struijk DG; Dinkla C; Stolk LM; ten Berge IJ; Krediet RT J Lab Clin Med; 1995 Aug; 126(2):204-15. PubMed ID: 7636393 [TBL] [Abstract][Full Text] [Related]
10. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis. Lai KN; Lai KB; Lam CW; Chan TM; Li FK; Leung JC Am J Kidney Dis; 2000 Apr; 35(4):644-52. PubMed ID: 10739785 [TBL] [Abstract][Full Text] [Related]
11. Endotoxin-stimulated peritoneal macrophages obtained from continuous ambulatory peritoneal dialysis patients show an increased capacity to release interleukin-1 beta in vitro during infectious peritonitis. Fieren MW; Van den Bemd GJ; Bonta IL Eur J Clin Invest; 1990 Aug; 20(4):453-7. PubMed ID: 2121505 [TBL] [Abstract][Full Text] [Related]
12. Peritoneal macrophages from patients on CAPD show an increased capacity to secrete interleukin-1 beta during peritonitis. Fieren MW; van den Bemd GJ; Bonta IL Adv Perit Dial; 1990; 6():120-2. PubMed ID: 1982787 [TBL] [Abstract][Full Text] [Related]
13. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship. Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642 [TBL] [Abstract][Full Text] [Related]
14. [Milrinone suppresses TNF-alpha and IL-1 beta release in mouse peritoneal macrophages]. Masaki Y; Sato W; Kayaba M; Enzan K; Suzuki M Masui; 1995 Jun; 44(6):800-4. PubMed ID: 7637154 [TBL] [Abstract][Full Text] [Related]
15. Peritonitis in continuous ambulatory peritoneal dialysis: cytokines in peritoneal fluid and blood. Enríquez J; Klínger J; Arturo JA; Delgado M; Tobar C; Mosquera M Adv Perit Dial; 2002; 18():177-83. PubMed ID: 12402614 [TBL] [Abstract][Full Text] [Related]
16. Reduced secretion of IL-1 beta by peritoneal cells from patients on continuous ambulatory peritoneal dialysis. Hart PH; Jones CA; Jones KL; Finlay-Jones JJ Immunol Cell Biol; 1993 Apr; 71 ( Pt 2)():99-107. PubMed ID: 8486401 [TBL] [Abstract][Full Text] [Related]
17. Longitudinal evaluation of peritoneal macrophage function and activation during CAPD: maturity, cytokine synthesis and arachidonic acid metabolism. McGregor SJ; Topley N; Jörres A; Speekenbrink AB; Gordon A; Gahl GM; Junor BJ; Briggs JD; Brock JH Kidney Int; 1996 Feb; 49(2):525-33. PubMed ID: 8821840 [TBL] [Abstract][Full Text] [Related]
18. Disparate cytochemical characteristics and production of cytokines and prostaglandin E2 by human mononuclear phagocytes from the blood, lung, and peritoneal cavity. Friedlander MA; Hilbert CM; Wu YC; Finegan CK; Rich EA J Lab Clin Med; 1994 Apr; 123(4):574-84. PubMed ID: 8145006 [TBL] [Abstract][Full Text] [Related]
19. Cytokines and peritonitis in continuous ambulatory peritoneal dialysis: immunodeviation and immunodeficiency. Klínger J; Enríquez J; Arturo JA; Delgado M; Avila G; Ceballos O Adv Perit Dial; 2002; 18():170-6. PubMed ID: 12402613 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-8 production by human peritoneal mesothelial cells in response to tumor necrosis factor-alpha, interleukin-1, and medium conditioned by macrophages cocultured with Staphylococcus epidermidis. Betjes MG; Tuk CW; Struijk DG; Krediet RT; Arisz L; Hart M; Beelen RH J Infect Dis; 1993 Nov; 168(5):1202-10. PubMed ID: 8228354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]